Items where Author is "Hendrix, CW"

Article

Mcgowan, I and Cranston, RD and Duffill, K and Siegel, A and Engstrom, JC and Nikiforov, A and Jacobson, C and Rehman, KK and Elliott, J and Khanukhova, E and Abebe, K and Mauck, C and Spiegel, HML and Dezzutti, CS and Rohan, LC and Marzinke, MA and Hiruy, H and Hendrix, CW and Richardson-Harman, N and Anton, PA (2015) A phase 1 randomized, open label, rectal safety, acceptability, pharmacokinetic, and pharmacodynamic study of three formulations of tenofovir 1% Gel (the CHARM-01 study). PLoS ONE, 10 (5).

Richardson-Harman, N and Hendrix, CW and Bumpus, NN and Mauck, C and Cranston, RD and Yang, K and Elliott, J and Tanner, K and McGowan, I and Kashuba, A and Anton, PA (2014) Correlation between compartmental tenofovir concentrations and an ex vivo rectal biopsy model of tissue infectibility in the RMP-02/MTN-006 phase 1 study. PLoS ONE, 9 (10).

Hendrix, CW and Chen, BA and Guddera, V and Hoesley, C and Justman, J and Nakabiito, C and Salata, R and Soto-Torres, L and Patterson, K and Minnis, AM and Gandham, S and Gomez, K and Richardson, BA and Bumpus, NN (2013) MTN-001: Randomized Pharmacokinetic Cross-Over Study Comparing Tenofovir Vaginal Gel and Oral Tablets in Vaginal Tissue and Other Compartments. PLoS ONE, 8 (1).

Dezzutti, CS and Hendrix, CW and Marrazzo, JM and Pan, Z and Wang, L and Louissaint, N and Kalyoussef, S and Torres, NM and Hladik, F and Parikh, U and Mellors, J and Hillier, SL and Herold, BC (2011) Performance of swabs, lavage, and diluents to quantify biomarkers of female genital tract soluble mucosal mediators. PLoS ONE, 6 (8).